Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone (Q44598595)
Jump to navigation
Jump to search
scientific article published on October 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone |
scientific article published on October 1, 2003 |
Statements
1 reference
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone (English)
1 reference
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone (English)
1 reference
Elizabeth M Brunt
1 reference
Dana Oliver
1 reference
Brent A. Neuschwander-Tetri
Kent R. Wehmeier
1 October 2003
1 reference
1 reference
1 reference
346
393
Diabetes Prevention Program Research Group
2002
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference